← Back to Discover

Remedium Capital Partners, LLC

Period ended Sep 30, 2026 · Latest filing Nov 13, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Sep 30, 2026: $273,591,243

More quarters will appear as history becomes available.

Top holdings

Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. Spyre Therapeutics Inc · COM · 00773J202 · shares: $103,329,999
  2. Oruka Therapeutics Inc · COM · 687604108 · shares: $79,471,154
  3. Damora Therapeutics Inc · COM · G2646Y104 · shares: $43,527,665
  4. Jade Biosciences Inc · COM · 008064206 · shares: $25,399,787
  5. Korsana Biosciences Inc · COM · 23255M303 · shares: $16,592,000
  6. Crescent Biopharma Inc · COM · G2545C104 · shares: $5,270,638

Reported holdings

6 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
Spyre Therapeutics IncCOM00773J202 — 1,160,620 shares $103,329,999
Oruka Therapeutics IncCOM687604108 — 954,150 shares $79,471,154
Damora Therapeutics IncCOMG2646Y104 — 2,045,473 shares $43,527,665
Jade Biosciences IncCOM008064206 — 1,807,814 shares $25,399,787
Korsana Biosciences IncCOM23255M303 — 518,500 shares $16,592,000
Crescent Biopharma IncCOMG2545C104 — 361,250 shares $5,270,638